AngioDynamics ANGO
$11.73 −$0.08 (-0.68%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $11.73 0.00%
Open$11.62
Prev close$11.81
Day range$11.52 – $11.81
Volume363.7K
Market cap$493.30M
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±14.4%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+37.7%
Worst reaction-27.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q1 | 8 Oct 2026 | Pre Market | ±13.9% | -20.86% | Bigger than priced |
| 2026/Q4 | 14 Jul 2026 | Pre Market | ±11.9% | +1.76% | Within range |
| 2026/Q3 | 2 Apr 2026 | Pre Market | ±14.2% | -13.65% | Within range |
| 2026/Q2 | 6 Jan 2026 | Pre Market | ±13.3% | -13.53% | Bigger than priced |
| 2026/Q1 | 2 Oct 2025 | Pre Market | ±13.6% | +6.05% | Within range |
| 2025/Q4 | 15 Jul 2025 | Pre Market | ±24.4% | -10.18% | Within range |
| 2025/Q3 | 2 Apr 2025 | Pre Market | ±23.3% | +12.42% | Within range |
| 2025/Q2 | 8 Jan 2025 | Pre Market | ±24.0% | +37.66% | Bigger than priced |
| 2025/Q1 | 3 Oct 2024 | Pre Market | ±27.7% | -16.73% | Within range |
| 2024/Q4 | 16 Jul 2024 | Pre Market | ±21.8% | +26.64% | Bigger than priced |
| 2024/Q3 | 4 Apr 2024 | Pre Market | ±37.5% | +5.26% | Within range |
| 2024/Q2 | 5 Jan 2024 | Pre Market | ±19.8% | -19.87% | Bigger than priced |
| 2024/Q1 | 4 Oct 2023 | Pre Market | ±16.8% | -2.63% | Within range |
| 2023/Q4 | 12 Jul 2023 | Pre Market | ±17.5% | -1.71% | Within range |
| 2023/Q3 | 30 Mar 2023 | Pre Market | ±17.4% | -27.02% | Bigger than priced |
| 2023/Q2 | 5 Jan 2023 | Pre Market | ±19.0% | +13.74% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/FY
By business line
By region
Fundamentals
Latest reported quarter: Q1, ended Aug 2026
Revenue$80.92M+6.9% YoY
Operating profit-$5.12M+35.2% YoY
Net profit-$7.10M+34.9% YoY
Diluted EPS-$0.17+34.6% YoY
Free cash flow-$15.71M+5.6% YoY
Operating cash flow-$15.33M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin55.7%
Operating margin-6.0%
Net margin-10.1%
Return on equity-19.2%
Return on assets-13.0%
Return on invested capital-19.2%
Current ratio2.40
Liabilities / assets32.2%
Cash & investments$33.97M
Net cash (debt)$33.97M
Free cash flow / sales0.4%
No comments yet — be the first to weigh in on ANGO.
Sign in to join the discussion.